Infantile hepatic hemangioma (IHH) is the mostcommon benign tumor of the liver in the first yearof age. Treatment for IHH is historically medicaltherapy, including corticosteroids, interferon a, vincris-tine and cyclophosphamide.(1)Nevertheless, significantmorbidity and mortality have been reported.(2)Since2010, few experiences of patients with IHH successful-ly treated with oral propranolol as second- or first-linetherapy have been reported.(3)Herein, we describe aparticular case of life-threatening IHH successfullytreated with oral propranolol as first-line approach.

Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report / Varrasso, Giulia; Schiavetti, Amalia; Lanciotti, Silvia; Sapio, Maria; Ferrara, Eva; Grazia, Alessandra De; Clerico, Anna. - In: HEPATOLOGY. - ISSN 0270-9139. - ELETTRONICO. - 66:1(2017), pp. 283-285. [10.1002/hep.29028]

Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report

SCHIAVETTI, Amalia;Sapio, Maria;FERRARA, EVA;Grazia, Alessandra De;CLERICO, Anna
2017

Abstract

Infantile hepatic hemangioma (IHH) is the mostcommon benign tumor of the liver in the first yearof age. Treatment for IHH is historically medicaltherapy, including corticosteroids, interferon a, vincris-tine and cyclophosphamide.(1)Nevertheless, significantmorbidity and mortality have been reported.(2)Since2010, few experiences of patients with IHH successful-ly treated with oral propranolol as second- or first-linetherapy have been reported.(3)Herein, we describe aparticular case of life-threatening IHH successfullytreated with oral propranolol as first-line approach.
2017
prednisone; thyroxine; propranolol
01 Pubblicazione su rivista::01i Case report
Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report / Varrasso, Giulia; Schiavetti, Amalia; Lanciotti, Silvia; Sapio, Maria; Ferrara, Eva; Grazia, Alessandra De; Clerico, Anna. - In: HEPATOLOGY. - ISSN 0270-9139. - ELETTRONICO. - 66:1(2017), pp. 283-285. [10.1002/hep.29028]
File allegati a questo prodotto
File Dimensione Formato  
Varrasso_postprint_Propranolol_2017.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.14 MB
Formato Adobe PDF
2.14 MB Adobe PDF
Varrasso_Propanolol_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 181.15 kB
Formato Adobe PDF
181.15 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/963736
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 18
social impact